Aktiespot

Jilin Province Huinan Changlong Bio-pharmacy Company Limited (JILIN CHANGLONG) aksje

8049.HK

Stengt
HK$2.480+0.050 (+2.06%)
Laster graf...

JILIN CHANGLONG

Åpning2.430
Høy2.480
Lav2.430
Volum20k
P/E6.05
Markedsverdi1.39B
52-ukers høy2.600
52-ukers lav1.820
Gj.sn. volum65.6k
UtbytteN/A
Beta0.29
EPS0.410

Om Jilin Province Huinan Changlong Bio-pharmacy Company Limited (JILIN CHANGLONG) aksje

Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People's Republic of China. The company provides Edaravone injection, compound brain comfort capsules, haikun kidney capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine zinc gluconate tablets, and Qianlie Guihuang Tablets. It also engages in the manufacture and distribution of beverages and prepackaged food, as well as health products. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.

Selskapsinformasjon

Børs: HKSE (HKG)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Special og generisk
Adresse:
Grand Plaza, Office Tower Two
Kowloon, Hong Kong
Telefon: + 86 435 821 8333

Analytikernes aksjeanbefalinger

Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.

Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål

Andre ser også på: